Inhibitors of the Bacterial Enzyme ArgE as Potential Novel Antibiotics
2024
- 24Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage24
- Downloads16
- Abstract Views8
Artifact Description
Bacteria are becoming increasingly resistant to antibiotics, and therefore there is an urgent need to discover novel antibiotics targeting alternate pathways. This project studies inhibitors of dizinc metalloenzyme acetylornithine deacetylase (ArgE), an enzyme found in the arginine biosynthesis pathway of bacteria. Inhibiting this enzyme would kill bacteria without mechanism-based toxicity to humans. We screened classes of potential inhibitors and tested compounds in a 214 nm assay, finding IC50 values for the most potent inhibitors. We also tested select inhibitors in a thermal shift assay with Escherichia coli ArgE to determine the stability of the enzyme in the presence of inhibitors.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know